Polymyxin-resistant Pseudomonas aeruginosa assigned as ST245: First report in an intensive care unit in Sao Paulo, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Citação
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, v.16, p.147-149, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: Pseudomonas aeruginosa is a Gram-negative bacterium that causes severe infections, especially in hospitalised and immunocompromised patients. Polymyxins are the last therapeutic option to treat infections caused by this micro-organism. Here we describe a polymyxin-resistant P. aeruginosa assigned as sequence type (ST) 245 for the first time in Brazil. Methods: Antimicrobial susceptibility testing of the isolate was performed. In addition, whole-genome sequencing was performed and its virulence and resistance genes were analysed. Results: The P. aeruginosa ST245 isolate was identified for the first time in Brazil in a patient with ventilator-associated pneumonia hospitalised at Hospital das Clinicas, Sao Paulo. Analysis of the genome showed the presence of several resistance and virulence genes. Mutations in beta-lactam resistance genes were found in beta-lactamases, outer membrane proteins, efflux pump and penicillin-binding proteins. Polymorphisms related to pathways leading to polymyxin resistance are also present, such as lipid A or keto-deoxyoctulosonate modification with aminoarabinose as well as activation of lipopolysaccharide (LPS). Conclusion: Such findings may represent an alert for the spread of an unusual profile in the country.
Palavras-chave
Pseudomonas aeruginosa, Fosfomycin, Polymyxin resistance
Referências
  1. Cho HH, 2014, ANN LAB MED, V34, P286, DOI 10.3343/alm.2014.34.4.286
  2. Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12
  3. Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07
  4. Lee JY, 2013, J MED MICROBIOL, V62, P1015, DOI 10.1099/jmm.0.055426-0
  5. Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643